14:30 CET, United States, GDP and PCE reports:
-
US GDP QoQ Advance Actual 1.5% (Forecast 2%, Previous 2.1%)
-
US Core PCE Price Index YoY Actual 3.3% (Forecast 3.3%, Previous 3.4%)
-
US Core PCE Price Index MoM Actual 0.1% (Forecast 0.2%, Previous 0.3%)
-
US Real Personal Consumption MoM Actual 0.3% (Forecast 0.4%, Previous 0.3%, Revised 0.4%)
In the second quarter of 2026, the US economy grew at a slower pace than expected, expanding by 1.5% on an annualised basis, as the Iran war weighed on confidence in the world’s largest economy. According to the BEA report, the slowdown was driven mainly by a decline in exports and government spending, as well as weaker business investment. Personal consumption also fell short of expectations, with US consumers continuing to feel the pressure from elevated fuel prices. The Core PCE numbers, Fed's prefered inflation measure, slightly missed the expectations (the monthly reading came in lower than expected, poitning to a milder, short-term inflationary pressure).
Private consumption still remains the backbone of the US GDP. Source: Macrobond, XTB Research
Technical Analysis: EURUSD (M30)
After an initial period of inertia, the most-traded currency pair resumed trading above its 10-period exponential moving average (EMA10, yellow), riding the post-Fed bullish wave.
EURUSD is currently testing the key resistance level around 1.1480 for the first time in two weeks. However, the bulls may struggle to push the pair towards the psychological 1.1500 level, as the short-term RSI remains close to overbought territory.
Holding above the 1.1450 mark, which aligns with both the 30-period EMA (light purple) and the 23.6% Fibonacci retracement level, will be crucial for maintaining the post-FOMC gains.
Source: xStation5
Daily Summary: Equities rally on not-so-hawkish Fed and AI trade revival, Yen dominates FX, oil retreats (30.07.2026)
Unexpected FX intervention? USDJPY plummets more than 2%! 🇯🇵
Nasdaq futures rally more than 3% 🚀
US OPEN: Nasdaq rebounds! Microsoft and Lam Research earnings revive AI trade!
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.